/
BON
$1.21+$0.08 (+7.08%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$9.2M
8M shares
52-week range
$1.13 – $3.40
4% from low
Exchange
NASDAQ
CS
Borrow rate
8.74%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-1711.29
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8M | $16.4M | $18.2M | $25.5M | $29.9M | $29.5M | $23.8M | $18.7M |
| Cost of revenue | $8.4M | $11.1M | $13.0M | $18.4M | $20.5M | $20.7M | $16.7M | $14.8M |
| Gross profit | $2.4M | $5.3M | $5.2M | $7.1M | $9.4M | $8.8M | $7.1M | $3.9M |
| Gross margin | 22.0% | 32.2% | 28.6% | 27.9% | 31.5% | 29.9% | 29.8% | 20.8% |
| R&D | $556.1K | $522.9K | $205.4K | $249.1K | $424.6K | $298.5K | $1.6M | $754.2K |
| Operating income | $602.1K | $3.2M | $3.5M | $5.4M | $7.9M | $5.9M | $1.9M | −$1.6M |
| EBITDA | $826.2K | $3.5M | $3.7M | $6.1M | $8.4M | $7.0M | $2.3M | −$57.8K |
| Net income | $223.4K | $2.6M | $3.0M | $4.6M | $6.2M | $4.6M | $398.2K | −$2.0M |
| Net margin | 2.1% | 15.7% | 16.6% | 18.0% | 20.9% | 15.6% | 1.7% | -10.7% |
| EPS (diluted) | 0.43 | 4.98 | 5.80 | 170.00 | 185.75 | 125.00 | 0.17 | -0.72 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $91M | $0.00 | $0.00–$0.00 | 0 |
| 2027 | $105M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$12.39
Price
$1.21
Implied upside
+924%
Peer comparison
Bon Natural Life Limited Class A Ordinary Shares
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
www.bnlus.com- Employees
- 96
- IPO / List date
- Jun 24, 2021
Held by traders on TradeandTell
No one on the platform currently holds BON.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BON as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-05-19 | 1-for-25reverse |
| 2024-04-11 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded BON yet.
